| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10922431 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 529 journal articles in the PubMed database | Email to a friend | | |
| Giri S, Mitchel JF, Hirst JA, et al.
Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction. [Journal Article]
Am J Cardiol 2000 Aug 1; 86(3):269-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Murdock DK, Logemann T, Hoffmann MT, et al.
Coronary artery stenting for suboptimal PTCA results in acute myocardial infarction in patients treated with Abciximab: early and six-month outcome. [Journal Article]
Cathet Cardiovasc Diagn 1997 Oct; 42(2):173-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Giri S, Mitchel J, Azar RR, et al.
Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. [Journal Article]
Am J Cardiol 2002 Jan 15; 89(2):126-31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Stone GW, Grines CL, Cox DA, et al.
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2002 Mar 28; 346(13):957-66.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Chan AW, Chew DP, Bhatt DL, et al.
Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. [Journal Article]
Am J Cardiol 2002 Jan 15; 89(2):132-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lincoff AM, Califf RM, Moliterno DJ, et al.
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 1999 Jul 29; 341(5):319-27.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Cox DA, Stone GW, Grines CL, et al.
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Am Coll Cardiol 2003 Sep 17; 42(6):971-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tcheng JE, Kandzari DE, Grines CL, et al.
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Circulation 2003 Sep 16; 108(11):1316-23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Cura FA, Bhatt DL, Lincoff AM, et al.
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Circulation 2000 Jul 4; 102(1):28-34.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
